Form4insider filings, from the source

SEC Form 4 · accession 0001225208-18-002808

JOHNSON & JOHNSON · JNJ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Joaquin Duato
Officer — Exec VP, WW Chair, Pharma
Period of report
Feb 9, 2018
Accepted (ET)
Feb 13, 2018 · 6:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000200406

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 9, 2018M9,812$0.00A78,348D
Common StockF2Feb 9, 2018F3,668$128.18D74,680D
Common StockF3holding———602IBy 401k

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Share UnitsF1—Feb 9, 2018M9,812DFeb 9, 2018—Common Stock9,8120D

Explanation of responses